Financial Performance - The company reported revenue of HKD 140,300,000 for the fiscal year ending June 30, 2022, an increase of approximately 27.9% compared to HKD 109,700,000 for the previous fiscal year[7]. - Profit attributable to equity holders for the year was approximately HKD 58,600,000, a decrease of about 3.9% from HKD 61,000,000 in the prior year[15]. - Revenue from healthcare staffing solutions was approximately HKD 106,900,000, up from HKD 92,100,000, reflecting an increase of about 14.8%[15]. - Revenue from outreach case assessment services grew by approximately 67.9% to about HKD 28,200,000, driven by increased demand for medical and health assessment services[15]. - The total revenue for the year was approximately HKD 140.3 million, representing an increase of about 27.9% compared to approximately HKD 109.7 million for the year ended June 30, 2021[22]. - Revenue from healthcare staffing solutions was approximately HKD 106.9 million, an increase of about HKD 14.8 million from approximately HKD 92.1 million in the previous year, with institutional staffing solutions contributing approximately HKD 75.2 million, up 26.0%[22]. - The net profit for the year was approximately HKD 58.6 million, a decrease of about 3.9% from approximately HKD 61 million in the previous year, with a net profit margin dropping to about 41.8%[29]. - Other income remained stable at approximately HKD 4.1 million, while other losses amounted to approximately HKD 2.5 million, primarily due to fair value changes in financial assets[24]. Business Strategy and Expansion - The company plans to further develop and expand its core business operations and geographic reach, particularly in the Guangdong-Hong Kong-Macao Greater Bay Area[9]. - The company aims to conduct feasibility studies for providing medical services in the Greater Bay Area, indicating potential market expansion[9]. - The group expects continued challenges in the global capital markets in 2023 but remains optimistic about long-term growth opportunities due to increasing demand for healthcare staffing solutions[19]. Corporate Governance - The company emphasizes high standards of corporate governance to manage business risks and enhance transparency, adhering to the corporate governance code as per the Hong Kong Stock Exchange[56]. - The board of directors held four meetings during the year, with all directors attending at least 75% of the meetings[70]. - The company has a commitment to maintaining a strong internal control system to protect the overall interests of shareholders[56]. - The independent non-executive directors confirmed their independence in accordance with the listing rules, ensuring compliance with governance standards[67]. - The company has established a diversity policy for its board members, emphasizing equal opportunity and the importance of diverse perspectives in decision-making[91]. - The company has a formal and transparent process for determining the remuneration of its directors and senior management[79]. - The company’s board consists of three independent non-executive directors, ensuring a strong governance framework[75]. - The board will continue to review the effectiveness of the corporate governance structure to assess the need for changes in the separation of the chairman and CEO roles[111]. Environmental, Social, and Governance (ESG) Initiatives - The environmental, social, and governance (ESG) report provides an overview of significant issues impacting the group's operations, prepared with professional assistance[138]. - The group emphasizes sustainable development as an essential part of its business strategy to enhance long-term competitiveness[144]. - The board has established an Environmental, Social, and Governance (ESG) working group to oversee ESG-related risks and policies, comprising executive directors and key management personnel[157]. - The group aims to reduce air pollutant emissions by 5% by 2025, with a significant reduction in emissions observed in 2022 due to increased use of video conferencing[162]. - Total greenhouse gas emissions decreased from 23.20 metric tons of CO2 equivalent in 2021 to 20.81 metric tons in 2022, with a target to reduce emissions by 5% by 2025[167]. - The company has not generated any hazardous waste, focusing instead on reducing non-hazardous waste from office operations[169]. - The ESG working group conducts annual materiality assessments to understand stakeholder expectations and concerns, aiding in informed decision-making[158]. - The company emphasizes transparency and accountability in its ESG initiatives, engaging with stakeholders through multiple communication channels[158]. Financial Position and Assets - The group acquired two properties for a total consideration of HKD 175 million, funded by net proceeds from asset sales, internal resources, and a loan of HKD 70 million[18]. - As of June 30, 2022, the group maintained cash and cash equivalents of approximately HKD 86.3 million, an increase from HKD 56.7 million in 2021[35]. - The net current assets decreased from approximately HKD 127.2 million as of June 30, 2021, to approximately HKD 1.8 million as of June 30, 2022[35]. - The group secured bank financing of approximately HKD 295.2 million as of June 30, 2022, compared to HKD 150.2 million in 2021, with HKD 227 million undrawn[35]. - The weighted average effective annual interest rate for bank borrowings was 1.54% as of June 30, 2022, compared to none in 2021[35]. Employee and Operational Insights - The total employee cost for the year was approximately HKD 41.3 million, up from HKD 24.1 million in 2021, with a total of 67 employees as of June 30, 2022[50]. - Employee benefit expenses increased to approximately HKD 41.3 million from HKD 24.1 million in the previous year[26]. - The number of registered healthcare personnel with the group was approximately 25,000 as of June 30, 2022[16]. Shareholder Returns - The board proposed a final dividend of HKD 20,000,000 to shareholders, reflecting the company's commitment to providing returns[8]. - The company declared a special dividend of HKD 30 million on October 18, 2021, and a final dividend of HKD 20 million on December 8, 2022[43]. - The company aims to provide stable and sustainable returns to shareholders through its dividend policy, considering operational performance, cash flow, and financial condition[103].
百本医护(02293) - 2022 - 年度财报